While most PID patients with EBV sensitivity have an anti-EBV CTL defect, other PID patients have a specific EBV sensitivity by other mechanisms, such as XMEN (mutations in MAGT1) (68), or patients with mutations in CTPS1 (69). Here, MAGT1 is linked to pelvic inflammatory disease.